thiazolyl blue has been researched along with arsenic trioxide in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bondesson, L; Garwicz, S; Jönsson, C; Ljungberg, J; Ora, I; Pâhlman, S; Pörn-Ares, I | 1 |
| Goker, E; Karabulut, B; Omay, SB; Sanli, UA; Sezgin, C; Terzioglu, E; Uslu, R | 1 |
| Arima, T; Ishibashi, K; Ishitsuka, K; Kohara, K; Komorizono, Y; Oketani, M; Tuvdendorj, D | 1 |
| Cohen, FJ; Gui, D; Ikezoe, T; Koeffler, HP; Kumagai, T; O'Kelly, J; Said, JW; Tong, XJ | 1 |
| Tchounwou, PB; Yedjou, CG | 1 |
| Barberá, R; Farré, R; Laparra, JM; Montoro, R; Vélez, D | 1 |
| Baek, SY; Kim, EY; Kim, SH; Lee, SS; Shin, DH; Shin, JH | 1 |
| Chen, C; Jiang, X; Zhang, Z; Zhao, W | 1 |
| Akrami, SM; Habibi, L; Karimi, A; Madjd, Z | 1 |
9 other study(ies) available for thiazolyl blue and arsenic trioxide
| Article | Year |
|---|---|
Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.
Topics: Antigens, Differentiation; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caspase 3; Caspase Inhibitors; Caspases; Cell Differentiation; Cell Division; Cell Survival; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Neoplasm Transplantation; Neuroblastoma; Oxides; RNA, Messenger; Tetrazolium Salts; Thiazoles; Transplantation, Heterologous; Tretinoin; Tumor Cells, Cultured | 2000 |
Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Arsenic Trioxide; Arsenicals; Butylated Hydroxyanisole; Carcinogens; Cisplatin; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Flow Cytometry; Humans; Male; Ovarian Neoplasms; Oxides; Prostatic Neoplasms; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2000 |
Inhibition by arsenic trioxide of human hepatoma cell growth.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Cycle; Cell Division; Coloring Agents; Dose-Response Relationship, Drug; Flow Cytometry; Glutathione; Humans; Oxides; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured | 2002 |
RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by
Topics: Agar; Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Caspases; CD36 Antigens; Cell Cycle; Cell Differentiation; Cell Division; Cell Line, Tumor; Cell Survival; Genetic Linkage; Humans; Immunologic Deficiency Syndromes; Ligands; Luciferases; Male; Mice; Multiple Myeloma; Oxides; Prostatic Neoplasms; Receptors, Cytoplasmic and Nuclear; Tetrazolium Salts; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Transfection; U937 Cells; X Chromosome | 2004 |
In-vitro cytotoxic and genotoxic effects of arsenic trioxide on human leukemia (HL-60) cells using the MTT and alkaline single cell gel electrophoresis (Comet) assays.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Survival; Coloring Agents; Comet Assay; HL-60 Cells; Humans; Oxides; Silver Staining; Tetrazolium Salts; Thiazoles | 2007 |
As2O3-induced oxidative stress and cycle progression in a human intestinal epithelial cell line (Caco-2).
Topics: Arsenic Trioxide; Arsenicals; Caco-2 Cells; Cell Cycle; Cell Survival; G1 Phase; G2 Phase; Humans; Membrane Potentials; Mitochondria; Mitochondrial Membranes; Oxidative Stress; Oxides; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2008 |
Anticancer effect of arsenic trioxide on cholangiocarcinoma: in vitro experiments and in vivo xenograft mouse model.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cholangiocarcinoma; Disease Models, Animal; Heterografts; Humans; Mice, Inbred BALB C; Mice, Nude; Oxides; Staining and Labeling; Tetrazolium Salts; Thiazoles; Treatment Outcome | 2014 |
Sodium arsenite and arsenic trioxide differently affect the oxidative stress, genotoxicity and apoptosis in A549 cells: an implication for the paradoxical mechanism.
Topics: Annexin A5; Apoptosis; Arsenic Trioxide; Arsenicals; Arsenites; Cell Cycle; Cell Line, Tumor; Coloring Agents; Comet Assay; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; In Situ Nick-End Labeling; Micronucleus Tests; Mutagens; Oxidative Stress; Oxides; Reactive Oxygen Species; Sodium Compounds; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Tumor Stem Cell Assay | 2013 |
Exposure of hepatocellular carcinoma cells to low-level As₂O₃ causes an extra toxicity pathway via L1 retrotransposition induction.
Topics: Animals; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Coloring Agents; Deoxyribonuclease I; DNA; Flow Cytometry; Green Fluorescent Proteins; Humans; Indicators and Reagents; Liver Neoplasms; Liver Neoplasms, Experimental; Microscopy, Fluorescence; Oxides; Plasmids; Real-Time Polymerase Chain Reaction; Retroelements; Tetrazolium Salts; Thiazoles; Transfection | 2014 |